Biorce uses AI to slash clinical trial timelines by 50%, raising $61.5M to bridge the "valley of death" and get life-saving medicine to patients.

Tarjama uses proprietary AI and a 90% female workforce to bridge the Arabic digital gap, turning a $15M Series A into regional impact.